Baseline malaria infection status and RTS,S/AS01E malaria vaccine efficacy.
Juraska M, Early AM, Li L, Schaffner SF, Lievens M, Khorgade A, Simpkins B, Hejazi NS, Benkeser DA, Wang Q, Mercer LD, Adjei S, Agbenyega T, Anderson S, Ansong D, Bii DK, Buabeng PBY, English S, Fitzgerald N, Grimsby J, Kariuki SK, Otieno K, Roman F, Samuels AM, Westercamp N, Ockenhouse CF, Ofori-Anyinam O, Lee CK, MacInnis BL, Wirth DF, Gilbert PB, Neafsey DE.
Juraska M, et al.
medRxiv [Preprint]. 2023 Nov 23:2023.11.22.23298907. doi: 10.1101/2023.11.22.23298907.
medRxiv. 2023.
PMID: 38045387
Free PMC article.
Preprint.
BACKGROUND: The only licensed malaria vaccine, RTS,S/AS01 (E) , confers moderate protection against symptomatic disease. ...Improved VE in participants infected during vaccination could suggest new strategies for highly efficacious malaria vaccine development and im …
BACKGROUND: The only licensed malaria vaccine, RTS,S/AS01 (E) , confers moderate protection against symptomatic disease. ...Improved …